607 related articles for article (PubMed ID: 26063715)
1. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
[TBL] [Abstract][Full Text] [Related]
2. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Britt NS; Potter EM; Patel N; Steed ME
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2017 Mar; 64(5):605-613. PubMed ID: 28011602
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Patel R; Gallagher JC
Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
[TBL] [Abstract][Full Text] [Related]
6. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
[TBL] [Abstract][Full Text] [Related]
7. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
[TBL] [Abstract][Full Text] [Related]
8. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
9. Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis.
Zhao M; Liang L; Ji L; Chen D; Zhang Y; Zhu Y; Patel K
Int J Antimicrob Agents; 2016 Sep; 48(3):231-8. PubMed ID: 27475877
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
[TBL] [Abstract][Full Text] [Related]
11. Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.
Hayakawa K; Martin ET; Gudur UM; Marchaim D; Dalle D; Alshabani K; Muppavarapu KS; Jaydev F; Bathina P; Sundaragiri PR; Rajuri SD; Khatri J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
Antimicrob Agents Chemother; 2014 Jul; 58(7):3968-75. PubMed ID: 24798267
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.
Herc ES; Kauffman CA; Marini BL; Perissinotti AJ; Miceli MH
Leuk Lymphoma; 2017 Dec; 58(12):2852-2858. PubMed ID: 28402152
[TBL] [Abstract][Full Text] [Related]
13. Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience.
McKinnell JA; Arias CA
Clin Infect Dis; 2015 Sep; 61(6):879-82. PubMed ID: 26063714
[No Abstract] [Full Text] [Related]
14. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
[TBL] [Abstract][Full Text] [Related]
15. Clinical epidemiology of vancomycin-resistant
Britt NS; Potter EM
J Glob Antimicrob Resist; 2016 Jun; 5():57-61. PubMed ID: 27274980
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
Chuang YC; Wang JT; Lin HY; Chang SC
BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779
[TBL] [Abstract][Full Text] [Related]
19. Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.
Patel K; Kabir R; Ahmad S; Allen SL
J Oncol Pharm Pract; 2016 Apr; 22(2):212-8. PubMed ID: 25326010
[TBL] [Abstract][Full Text] [Related]
20. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Tamma PD; Hsu AJ
Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]